Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Doncel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current HIV/AIDS Reports|August 11, 2005
Vaginal microbicides: a novel approach to preventing sexual transmission of HIVGustavo Doncel, Christine Mauck
Current Infectious Disease Reports|November 28, 2001
An Update on Vaginal MicrobicidesChristine Mauck, Gustavo Doncel
Fertility and Sterility|November 5, 2002
Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxisLourens J D Zaneveld, Robert A Anderson, Xiao Hui Diao, et al.
AIDS Research and Human Retroviruses|November 15, 2016
Analytical Advances in the Ex Vivo Challenge Efficacy AssayNicola Richardson-Harman, Robert Parody, Peter Anton, et al.
AIDS Research and Human Retroviruses|October 18, 2005
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trialsDeborah Tien, Roger L Schnaare, Feirong Kang, et al.
AIDS Research and Human Retroviruses|July 24, 2015
Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal ImmunityAndrea Ries Thurman, Thomas Kimble, Betsy Herold, et al.
AIDS Research and Human Retroviruses|September 20, 2021
An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil FumarateIan M McGowan, Ratiya Pamela Kunjara Na Ayudhya, Rhonda M Brand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2026
A comparison of F/TAF and F/TDF as HIV pre-exposure prophylaxis in a predominantly cisgender women population in East and South Africa: a randomised, factorial, non-inferiority trialSheena McCormack, David Dunn, Sylvia Kusemererwa, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current HIV/AIDS Reports|August 11, 2005
Vaginal microbicides: a novel approach to preventing sexual transmission of HIVGustavo Doncel, Christine Mauck
Current Infectious Disease Reports|November 28, 2001
An Update on Vaginal MicrobicidesChristine Mauck, Gustavo Doncel
Fertility and Sterility|November 5, 2002
Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxisLourens J D Zaneveld, Robert A Anderson, Xiao Hui Diao, et al.
AIDS Research and Human Retroviruses|November 15, 2016
Analytical Advances in the Ex Vivo Challenge Efficacy AssayNicola Richardson-Harman, Robert Parody, Peter Anton, et al.
AIDS Research and Human Retroviruses|October 18, 2005
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trialsDeborah Tien, Roger L Schnaare, Feirong Kang, et al.
AIDS Research and Human Retroviruses|July 24, 2015
Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal ImmunityAndrea Ries Thurman, Thomas Kimble, Betsy Herold, et al.
AIDS Research and Human Retroviruses|September 20, 2021
An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil FumarateIan M McGowan, Ratiya Pamela Kunjara Na Ayudhya, Rhonda M Brand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2026
A comparison of F/TAF and F/TDF as HIV pre-exposure prophylaxis in a predominantly cisgender women population in East and South Africa: a randomised, factorial, non-inferiority trialSheena McCormack, David Dunn, Sylvia Kusemererwa, et al.
Pageof 1